Educational guide
Livagen Dosage Protocol | PeptideDosages.com
Livagen (20 mg Vial) Dosage Protocol Livagen Dosage Chart Livagen is dosed at 500 mcg–2 mg daily via subcutaneous injection in educational protocols. A 20 mg vial reconstituted with bacteriostatic water yields about 6.67 mg/mL. This information is for research
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Livagen (20 mg Vial) Dosage Protocol
Livagen Dosage Chart
Livagen is dosed at 500 mcg–2 mg daily via subcutaneous injection in educational protocols. A 20 mg vial reconstituted with bacteriostatic water yields about 6.67 mg/mL. This information is for research and educational use only.
Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration.
Typical daily range: 0.5–2.0 mg once daily (gradual titration over 8–12 weeks).
Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 0.0667 mg (66.7 mcg) on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
Livagen (Lys-Glu-Asp-Ala) is a synthetic tetrapeptide bioregulator studied for its effects on peptidase inhibition and epigenetic modulation in aging tissues[1][4]. Preclinical research demonstrates Livagen strongly inhibits enkephalin-degrading enzymes[1] and induces heterochromatin decondensation with gene reactivation in aged cells[4]. No standardized human dosing exists; this educational protocol presents a once-daily subcutaneous approach based on analogy with similar peptide bioregulators.
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read Livagen Peptide: Benefits, Uses, Side Effects, Dosage, and Research.
Standard / Gradual Approach (3 mL = ~6.67 mg/mL)
Weeks 1–2
0.5 mg (500 mcg)
7.5 units (0.075 mL)
Weeks 3–4
1.0 mg (1000 mcg)
15 units (0.15 mL)
Weeks 5–6
1.5 mg (1500 mcg)
22.5 units (0.225 mL)
Weeks 7–12
2.0 mg (2000 mcg)
30 units (0.30 mL)
Frequency: Inject once daily subcutaneously. This schedule uses a 3.0 mL dilution to yield measurable volumes on standard insulin syringes. For ≤10-unit (≤0.10 mL) administrations (e.g., the initial 7.5-unit dose), consider 30- or 50-unit insulin syringes for improved readability.
Reconstitution Steps
Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Supplies Needed
Plan based on an 8–16 week daily protocol with gradual titration.
Peptide Vials (Livagen, 20 mg each):
8 weeks ≈ 4 vials
12 weeks ≈ 7 vials
16 weeks ≈ 10 vials
Insulin Syringes (U-100):
Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
12 weeks (7 vials): 21 mL → 3 × 10 mL bottles
16 weeks (10 vials): 30 mL → 3 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100-count boxes
12 weeks: 168 swabs → recommend 2 × 100-count boxes
16 weeks: 224 swabs → recommend 3 × 100-count boxes